ERBB2 and breast carcinoma: For this reason we are currently engaged in a formal meta-analysis of all published studies that have used FISH or chromogenic in situ hybridisation to determine the HER-2/neu status and hope to clarify once and for all the controversial status of HER-2/neu as a prognostic factor in breast cancer.